5:29 PM
 | 
Oct 18, 2013
 |  BC Extra  |  Company News

Stallergenes, DBV to develop birch allergy product

Stallergenes S.A. (Euronext:GENP) and DBV Technologies (Euronext:DBV) will develop and commercialize a birch allergy product using DBV's Viaskin skin patch technology and birch pollen allergen from Stallergenes....

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >